PUBLISHED DATE : Feb 2020 | Pages : 284
Fill out your details & get your free sample
Transplant Diagnostics Market Size, Share, & Trends Analysis Report by Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes), and Geography (Europe, North America, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
284 Pages
37 Tables
178 Charts
5 Regions
18 Countries
14 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (REVENUE) | USD 1.7 BILLION (2025) |
| CAGR | 6% (2020 - 2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Product (Instruments & Software and Consumables & Test Kits), Application (Diagnostic and Research), Technology (Molecular and Non-Molecular), Transplantation Type (Solid Organ and Soft Tissue), End-Users (Standard Reference Laboratories, Hospitals & Transplant Centers, and Research & Academic Institutes) |
| Geographic Analysis | Europe, North America, APAC, Latin America, and Middle East & Africa |
| Countries Covered | Spain, France, Germany, UK, Italy, Canada, US, China, Japan, South Korea, India, Australia, Brazil, Argentina, Mexico, Saudi Arabia, Iran, South Africa, and Israel |
The transplant diagnostics market size to cross USD 1.7 billion by 2025, growing at a CAGR of 6% during the forecast period. The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.
This research report includes detailed segmentation by
The increasing usage of a wide array of reagents and test kits to perform transplant diagnostics tests is a significant factor affecting the growth of the reagents & consumables product segment. The segment is growing at a faster rate than the instruments & software product segment due to their recurring purchase by end-users for performing molecular and non-molecular transplant tests.
The instruments and software segment is growing due to the rise in organ and tissue transplantations and the adoption of advanced techniques. The segment is growing at a relatively slow pace than the consumables & test kits segment as it is capital intensive, and purchasing decisions for these equipment depend on financial resources and budget allocations.
The research application segment is likely to witness faster growth than the clinical application segment as the number of research activities and clinical trials related to transplantation, especially stem cells, is increasing worldwide. The increase in the number of clinical trials and ongoing research activities to improve clinical outcomes is encouraging end-users to effectively screen donors and recipients, perform compatibility assessments and diagnose complications such as organ rejection and infections using molecular and non-molecular tests.
The diagnostics applications segment is growing at a healthy rate and is expected to grow during the forecast period. Transplantation is the treatment of choice for several patients with end-stage organ failure diseases. Significant signs of progress have been achieved both in short-term outcomes and long-term graft survival due to the increasing availability of molecular and serological-based tests to monitor transplant patients. Hence, technological improvements have further increased the application of the segment.
The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the segment. The segment is growing at a faster rate with a CAGR of 8% during the forecast period. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment.
In 2019, the non-molecular technology segment accounted for a 38% share of the global transplant diagnostics market. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Several vendors are offering non-molecular testing products, which is further contributing to the growth.
The solid organ transplantation market segment accounted for a 58% share of the global transplant diagnostics market. Solid-organ transplantation has become vital in treating patients suffering from terminal illnesses. Therefore, the global number of solid organ transplantations is increasing at a healthy rate despite interruptions in the organ donation supply mechanism. Incidences of end-stage organ failures are high among patients with chronic diseases, thereby increasing the need for solid organ transplantations. The growth in hematological cancer cases is a key factor for the increasing demand for stem cell therapy worldwide.
Standard reference laboratories conduct tests to identify donor receiver compatibility pre-transplantation. As the number of organs, cells, and tissue replacements is growing worldwide, the demand for laboratory testing is likely to rise at a steady rate. Government financial support for these laboratories is another major factor for the growth of the segment.
Hospitals & transplant centers accounted for a 37% share of the global transplant diagnostics market in 2019. Healthcare professionals in hospitals and transplant centers use various instruments, accessories, and software for conducting pre and post-transplantation diagnostics tests. The market is growing at a healthy rate due to the adoption of advanced instruments accessories and software for organs, cells, and tissue transplantations. The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers. Also, favorable reimbursement for transplant diagnostics is another factor boosting the end-user segment.
North America is the major revenue contributor to the global transplant diagnostics market followed by Europe, APAC, Latin America, and MEA. The region contributed a share of 42% in the year 2019. North America is considered as an attractive market for transplant diagnostics due to high healthcare expenditure in the region.
The transplant diagnostics market in Europe is the second-largest market and accounted for 31% share of the global market. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC.
Brazil, Mexico, and Argentina are the major revenue contributors to the market in Latin America. The market in Brazil is driven by the increasing chronic disease population, which is leading to the demand for advanced medical treatment options for organ and tissue transplantations. However, the Latin American market is confronted with the unique challenge of infectious disease diagnostics. MEA accounts for the lowest share of the market. The small share can be attributed to poor deceased-donor transplantations in several MEA countries.
The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2019. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally.
Segmentation by Product
By End-user
By Transplant Type
By Technology
By Application
By Geography
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
Fill out your details & get your free sample
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
Want to know more about the report or any specific requirement?
Click to Email +1-312-235-2040
